Disclosure: WIIP is our brand. Joint Comfort is mentioned in this article as a product we selected and developed. It is evaluated alongside the same evidence applied to green lipped mussel supplementation in general.

This article is for informational purposes only and does not constitute medical advice. Green lipped mussel supplements do not treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement.

Green Lipped Mussel for Joint Health — What Does the Research Actually Show?

Green lipped mussel (Perna canaliculus) is found exclusively in New Zealand's coastal waters. It contains ETA, a rare omega-3 fatty acid absent from standard fish oil, that inhibits both COX and LOX inflammatory pathways simultaneously. A 2021 systematic review of nine clinical trials found GLM produced moderate and clinically significant reductions in osteoarthritis pain (Abshirini et al., 2021) [VERIFIED]. Research suggests GLM may support joint comfort through this dual-pathway inhibition — a mechanism that distinguishes it from standard fish oil, which primarily targets the COX pathway alone.

What Is Green Lipped Mussel?

Green lipped mussel (Perna canaliculus) — known as kūtai (or kuku) in te reo Māori — is a large bivalve shellfish found only in the coastal waters of New Zealand. It is not farmed anywhere else in the world. The species is named for the distinctive green edge along the shell's lip and has been a significant marine taonga (treasured species) for Māori communities for centuries. Archaeological evidence of GLM shells has been found in middens created by the earliest New Zealanders, and coastal Māori traditionally prepared them in earth ovens, dried them for preservation, or ate them raw.

Scientific interest in GLM's medicinal properties began in the 1960s and 1970s, when researchers observed that coastal Māori populations — whose traditional diet regularly included green lipped mussels — appeared to have lower rates of joint complaints compared to inland Māori communities. That observation launched over five decades of research into GLM's bioactive compounds, making it one of the longest-studied natural joint health ingredients in existence.

Today, New Zealand's GLM industry is both a significant export sector and a source of raw material for joint health supplements worldwide. But not all GLM supplements are created equal — the extraction and processing method matters enormously, and the science behind GLM's effects is more nuanced than most marketing materials suggest.

The Science Behind GLM and Joint Health

Green lipped mussel's joint health benefits are not attributable to a single compound. Rather, they appear to arise from a complex matrix of bioactive lipids, proteins, and polysaccharides working in combination. Understanding these components helps explain why GLM behaves differently from isolated supplements like glucosamine or standard fish oil.

Omega-3 Fatty Acids: EPA, DHA, and the Unique ETA

Like fish oil, GLM contains the well-known omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). These have established anti-inflammatory properties — they compete with arachidonic acid for the cyclooxygenase (COX) pathway, reducing the production of pro-inflammatory prostaglandins like PGE2.

However, GLM also contains ETA (eicosatetraenoic acid), a rare omega-3 fatty acid not found in standard fish oil supplements. ETA is clinically significant because it acts as a dual inhibitor of arachidonic acid metabolism — it inhibits both the cyclooxygenase (COX) pathway and the lipoxygenase (LOX) pathway. The LOX pathway produces leukotrienes, which are potent inflammatory mediators involved in conditions such as arthritis and asthma. Standard fish oil primarily targets the COX pathway; GLM targets both.

This dual-pathway inhibition is what gives GLM its distinctive anti-inflammatory profile. The bioactive lipids in GLM have been demonstrated to compete more efficiently than arachidonic acid for both COX and LOX pathways, resulting in decreased synthesis of both pro-inflammatory prostaglandins and leukotrienes (PMC8298224) [VERIFIED].

Anti-Inflammatory Mechanisms: COX-2 and LOX Pathways

To understand why GLM's dual-pathway action matters, consider how joint inflammation works at a cellular level. When joint tissue is damaged or stressed, the body releases arachidonic acid, which is then converted into inflammatory compounds through two main enzymatic pathways:

• COX-2 pathway: Produces prostaglandins (especially PGE2), which cause pain, swelling, and redness at the joint.
• 5-LOX pathway: Produces leukotrienes (especially LTB4), which recruit immune cells to the site and amplify the inflammatory response.

Most conventional anti-inflammatory approaches — including NSAIDs and standard fish oil — primarily target the COX pathway. GLM's omega-3 profile, particularly ETA, suppresses both cascades simultaneously. This is why some researchers have described GLM as having a broader anti-inflammatory mechanism than either fish oil or isolated omega-3 supplements.

Glycosaminoglycans: Natural Chondroitin Sulphate

Beyond its lipid profile, GLM contains naturally occurring glycosaminoglycans (GAGs) — the structural molecules that make up cartilage. These include chondroitin sulphate, heparan sulphate, and hyaluronic acid. A 2022 study isolated and characterised the specific GAG structures in Perna canaliculus, confirming the presence of chondroitin sulphate chains with a high degree of sulphation (Mubuchi et al., 2022) [VERIFIED].

This is noteworthy because chondroitin sulphate is one of the most widely used joint supplements in the world — but most commercial chondroitin is synthetically derived. GLM provides it in its natural matrix alongside the omega-3 fatty acids and other bioactive compounds. The practical implication is that GLM delivers both anti-inflammatory action (via the lipids) and structural cartilage support (via the GAGs) in a single source.

What Do Clinical Studies Say?

The clinical evidence for GLM in joint health has been building for over two decades. Here is what the published research shows — organised by condition and study quality.

Osteoarthritis: The Strongest Evidence

The most comprehensive assessment to date is the 2021 systematic review by Abshirini et al., published in Inflammopharmacology. The review included nine clinical trials, and five were pooled in a meta-analysis. The pooled results showed GLM extracts (both lipid extract and whole powder forms) provided a moderate and clinically meaningful treatment effect on pain, as measured by the visual analogue scale (VAS). The effect size was -0.46 (95% CI: -0.82 to -0.10; p = 0.01) [VERIFIED]. Improvements in stiffness, physical function, and physical aspects of quality of life were also observed across most included studies (Abshirini et al., 2021).

Individual trials within this body of evidence include:

Cho et al. (2003) — A multicentre, open-label clinical trial (without placebo control) of 60 patients with hip and knee osteoarthritis found that Lyprinol (a patented GLM lipid extract) led to significant improvement in pain, joint function, and physician-assessed outcomes after 8 weeks. Eighty percent of patients reported significant pain relief by the end of the treatment period. No adverse effects were reported (Cho et al., 2003) [VERIFIED].

Coulson et al. (2012) — An open-label study administered 3,000mg/day of GLM extract to 21 subjects with knee osteoarthritis over 8 weeks. GLM significantly improved knee joint pain, stiffness, and mobility. An interesting secondary finding was that GLM supplementation also significantly improved gastrointestinal symptoms by 49% (Coulson et al., 2012) [VERIFIED].

Coulson et al. (2013) — A follow-up study comparing 3,000mg/day of GLM whole extract powder with 3,000mg/day of glucosamine sulphate over 12 weeks in 38 participants (GLM 21, glucosamine 17). Both groups reported significant improvements in pain, stiffness, and function, with no significant difference between the two interventions [VERIFIED]. This suggests GLM performs comparably to glucosamine for osteoarthritis symptom management.

Stebbings et al. (2017) — A randomised, double-blind, placebo-controlled trial (the BioLex trial) of 80 patients with moderate to severe hip and knee OA tested 600mg/day of a novel GLM lipid extract over 12 weeks. The primary outcome did not reach statistical significance at week 12. However, a significant difference in paracetamol use was observed post-intervention (p = 0.001), and joint stiffness in the GLM group improved relative to placebo at week 15 (p = 0.046). The authors noted that higher doses and longer treatment periods may be warranted (Stebbings et al., 2017) [VERIFIED].

Munnangi et al. (2022) — A randomised, double-blind, placebo-controlled trial published in Frontiers in Medicine tested 3,000mg/day of whole GLM powder in 55 overweight/obese postmenopausal women over 12 weeks. In the overall study population, CTX-II (a biomarker of cartilage degradation) did not differ significantly between groups; the significant reduction was observed specifically in the subgroup with symptomatic knees (week 6, p=0.04). The study concluded that GLM may slow down the degradation of type II collagen and conferred clinical benefit on overall joint pain (Munnangi et al., 2022) [VERIFIED].

Rheumatoid Arthritis: Emerging Preclinical Evidence

A 2023 study by Yang et al. published in PLOS ONE investigated GLM in collagen-induced arthritis (CIA) mice — a standard model for rheumatoid arthritis. GLM reduced arthritis severity and histologic scores compared to controls. The expression of pro-inflammatory cytokines TNF-alpha, IL-1beta, and IL-17 was significantly decreased in GLM-treated animals. GLM also inhibited osteoclast formation, suggesting potential for reducing bone erosion in inflammatory arthritis (Yang et al., 2023) [VERIFIED].

This is promising but must be contextualised: it is an animal study. Human clinical trials specifically investigating GLM for rheumatoid arthritis are still limited. The preclinical evidence supports further investigation, but it would be premature to recommend GLM as a treatment for RA based on current data.

What GLM Cannot Do

The evidence supports a role for GLM in supporting joint comfort and potentially slowing aspects of cartilage degradation. It does not support claims that GLM treats, cures, or reverses arthritis. The systematic review noted that while treatment effects were moderate and clinically meaningful, the current evidence is limited by the number and quality of studies, and further larger, high-quality trials are needed to confirm effectiveness (Abshirini et al., 2021).

GLM vs Glucosamine vs Fish Oil

These three supplements are the most commonly used for joint health, but they work through different mechanisms. Understanding the differences helps you make an informed decision.

The key distinction: Glucosamine works primarily as a structural building block for cartilage. Fish oil works primarily as an anti-inflammatory through the COX pathway. GLM offers both structural support (via GAGs) and anti-inflammatory action (via the full omega-3 matrix including ETA), addressing two aspects of joint health simultaneously. The Coulson et al. (2013) head-to-head comparison found that GLM performed comparably to glucosamine over 12 weeks [VERIFIED].

GLM and glucosamine work through complementary mechanisms and can be taken together. There are no known adverse interactions between the two.

How to Choose a GLM Supplement in NZ

Not all GLM supplements deliver the same results. The processing method, source, and formulation all affect how much bioactive material reaches your joints. Here is what to look for:

*1. NZ-sourced Perna canaliculus. This is the species that has been researched for over 50 years. If the label does not specify Perna canaliculus* or "New Zealand green lipped mussel," ask the manufacturer to confirm.

2. Extraction and processing method. Freeze-dried whole powder preserves the full lipid matrix, including GAGs and the heat-sensitive omega-3 fatty acids. Heat-processed extracts may lose a portion of the bioactive compounds. Both forms have clinical evidence, but the processing method should be documented.

3. Adequate daily dose. Clinical trials have used doses ranging from 600mg to 3,000mg per day depending on the extract type. Most benefits in clinical trials were observed at 8–12 weeks of consistent daily use.

4. Supporting ingredients. Some GLM supplements are formulated with complementary compounds — L-carnitine (which supports cellular energy production) and vitamin D3 (which plays a role in bone and joint health). Since GLM naturally contains omega-3 fatty acids including EPA, DHA, and ETA, additional omega-3 supplementation is not necessarily required when taking a GLM-based product.

5. Heavy metal testing. New Zealand's marine waters are among the cleanest in the world, but responsible manufacturers still test for heavy metals, microbial contaminants, and environmental pollutants. Look for products that document testing on the label or upon request.

Dosage — How Much GLM Should You Take?

Clinical trial dosages for GLM vary considerably depending on the form of extract used:

Lipid extracts (concentrated oil): 200–600mg per day. The Cho et al. (2003) multicentre trial used a lipid extract and reported significant improvements. The Stebbings et al. (2017) BioLex trial used 600mg daily of a lipid extract.

Whole powder extracts: 1,000–3,000mg per day. The Coulson et al. (2012, 2013) trials used 3,000mg daily. The Munnangi et al. (2022) cartilage biomarker trial also used 3,000mg daily.

Practical recommendation based on the literature: For general joint support, a daily dose of 1,000–1,500mg of GLM extract is a reasonable starting point. Clinical benefits are most commonly observed after 8–12 weeks of consistent daily use — this is not a supplement that produces overnight results.

Timing: GLM is typically taken with food to improve absorption and reduce the chance of mild gastrointestinal discomfort. Splitting the daily dose across two meals (morning and evening) is a practical approach.

Side Effects and Precautions

GLM has demonstrated a good safety profile across clinical trials. The 2021 systematic review noted that both lipid and powdered whole extract products were "generally well tolerated and safe to use," with the exception of some minor gastrointestinal side effects (Abshirini et al., 2021) [VERIFIED].

Common mild side effects (infrequent and generally self-limiting):

• Mild stomach discomfort, gas, or nausea — particularly when taken on an empty stomach
• These effects are typically manageable by taking GLM with food

Shellfish allergy — this is a firm contraindication. GLM is a shellfish product. If you have a known allergy to shellfish, do not take GLM supplements.

Blood-thinning medications. Because GLM contains omega-3 fatty acids, which have a mild anticoagulant effect, you should consult your healthcare provider before taking GLM if you are on anticoagulant or antiplatelet medications (e.g. warfarin, aspirin, clopidogrel). The interaction risk is low but warrants medical guidance.

Pregnancy and breastfeeding. There is insufficient safety data on GLM supplementation during pregnancy or breastfeeding. Avoid use unless directed by your healthcare provider.

A Chiropractor's Perspective on Joint Supplements

In 12 years of clinical practice at Auckland Wellness Centre, I see joint pain patients every day — from office workers with stiff knees to retirees managing long-standing osteoarthritis. One of the most common questions I hear is whether a supplement can "fix" their joints.

The honest answer is that no supplement replaces structural care. If your joint pain is caused by biomechanical dysfunction — misalignment, restricted range of motion, muscle imbalance — that needs to be addressed through manual treatment and targeted rehabilitation. A capsule cannot correct a structural problem.

But supplements can play a meaningful supporting role. Joint health involves two parallel processes: managing the inflammatory response (which drives pain and swelling) and supporting the structural integrity of cartilage and connective tissue. Chiropractic care addresses the structural side. GLM, based on the clinical evidence, may help support the inflammatory and cartilage-maintenance side.

This is why I selected and developed WIIP Joint Comfort with GLM 1,000mg per serving as the primary ingredient, combined with L-Carnitine 200mg and Vitamin D3 800 IU — the GLM itself provides naturally occurring omega-3 fatty acids including EPA, DHA, and ETA, supporting different aspects of the joint health pathway. Two capsules per day deliver one full serving. It is not a replacement for clinical care. It is designed to work alongside it.

View WIIP Joint Comfort — $64.99, 120 Capsules (2 per serving), NZ-Made

Frequently Asked Questions

How long does it take for green lipped mussel to work?

Most clinical trials showing significant improvements in joint pain and function used treatment periods of 8–12 weeks [VERIFIED]. GLM is not a fast-acting pain reliever — it works by modulating inflammatory pathways and supporting cartilage metabolism over time. Consistency matters more than dose size. If you have not noticed any improvement after 12 weeks of daily use at an adequate dose, GLM may not be the right supplement for your particular situation.

Can I take green lipped mussel with glucosamine?

Yes. GLM and glucosamine work through complementary mechanisms — GLM provides anti-inflammatory action (via omega-3s and ETA) plus natural GAGs, while glucosamine supports proteoglycan synthesis in cartilage. There are no known adverse interactions between the two.

Is green lipped mussel better than fish oil for joints?

They work through different mechanisms. Standard fish oil contains EPA and DHA, which primarily inhibit the COX inflammatory pathway. GLM contains EPA and DHA plus ETA, which inhibits both the COX and LOX pathways — a broader anti-inflammatory profile. GLM also contains naturally occurring glycosaminoglycans (chondroitin sulphate) that fish oil does not provide. For joint-specific support, the research suggests GLM may offer advantages over standard fish oil due to this dual mechanism. For general cardiovascular and systemic inflammation, fish oil has a larger evidence base.

Is NZ green lipped mussel better than imported varieties?

Perna canaliculus — the New Zealand green lipped mussel — is the specific species that has been the subject of over 50 years of clinical and preclinical research. Other mussel species from other regions have not been studied to the same extent. When the research refers to "green lipped mussel," it is referring to Perna canaliculus* sourced from New Zealand waters.

Can green lipped mussel replace my arthritis medication?

No. GLM is a dietary supplement, not a pharmaceutical. It may support joint comfort alongside your existing treatment plan, but it should never be used as a replacement for prescribed arthritis medication without explicit guidance from your doctor.

Who should not take green lipped mussel?

People with a known shellfish allergy should not take GLM in any form. Those on anticoagulant medications should consult their doctor before starting GLM due to its omega-3 content. Pregnant or breastfeeding women should avoid GLM due to insufficient safety data.

Is green lipped mussel safe for long-term use?

The clinical trials reviewed in the 2021 systematic review used treatment periods of up to 12 weeks. Published clinical trial data supports safe use up to six months in the longest available studies [VERIFIED]. No serious adverse events have been attributed to GLM supplementation in the clinical literature. For longer-term use beyond these studied periods, periodic review with your healthcare provider is prudent.

Sources

1. Abshirini, M. et al. (2021). "Green-lipped (greenshell) mussel (Perna canaliculus) extract supplementation in treatment of osteoarthritis: a systematic review." Inflammopharmacology. PMC8298224
2. Cho, S.H. et al. (2003). "Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial." European Annals of Allergy and Clinical Immunology. PubMed
3. Coulson, S. et al. (2012). "Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study." Inflammopharmacology. PubMed
4. Coulson, S. et al. (2013). "Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles." Inflammopharmacology.
5. Stebbings, S. et al. (2017). "A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex- for managing pain in moderate to severe osteoarthritis of the hip and knee." BMC Complementary Medicine and Therapies. PMC5568208
6. Munnangi, S. et al. (2022). "Effects of Greenshell mussel intervention on biomarkers of cartilage metabolism, inflammatory markers and joint symptoms in overweight/obese postmenopausal women: a randomized, double-blind, and placebo-controlled trial." Frontiers in Medicine. PMC9760926
7. Yang, S. et al. (2023). "A green-lipped mussel prevents rheumatoid arthritis via regulation of inflammatory response and osteoclastogenesis." PLOS ONE. PMC9858385
8. Jhun, J. et al. (2021). "A green-lipped mussel reduces pain behavior and chondrocyte inflammation and attenuated experimental osteoarthritis progression." PLOS ONE. PMC8638931
9. Mubuchi, A. et al. (2022). "Isolation and structural characterization of bioactive glycosaminoglycans from the green-lipped mussel Perna canaliculus." Biochemical and Biophysical Research Communications. PubMed
10. WebMD. "New Zealand Green-Lipped Mussel: Uses, Side Effects, Interactions, Dosing." Link

Dr. Jun is a Senior Chiropractor at Auckland Wellness Centre with 12 years of clinical experience. He holds qualifications from the New Zealand College of Chiropractic (NZCC) and is certified in Titleist Performance Institute (TPI) assessment and Active Release Techniques (ART). Dr. Jun selected and developed WIIP Joint Comfort based on clinical experience with musculoskeletal patients and published research on GLM's bioactive compounds, with a focus on evidence-based ingredient selection and NZ-sourced materials.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new supplement. Green lipped mussel supplements are not intended to treat, cure, or prevent any disease.